Law firm Parker Waichman LLP has filed multiple lawsuits alleging patients developed NAION, an irreversible eye condition causing permanent vision loss, after taking Novo Nordisk's semaglutide drugs Ozempic and Wegovy. The lawsuits cite research linking semaglutide to increased NAION risk. The litigation alleges the manufacturer failed to adequately warn about the eye-injury risk.
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.